Atossa Genetics Pulls In $106K in Q3 Revenues
December 20, 2012
Atossa Genetics Pulls In $106K in Q3 Revenues
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Atossa Lowers Expected Share Price for Planned IPO, Reports $223K in Q2 Revenues
August 21, 2012 / GenomeWeb Daily News - Atossa Genetics Reports Loss of $482,436 as It Prepares for IPO
December 6, 2010 / GenomeWeb Daily News - After Formal Launch, Atossa Focused on Growing Adoption of ForeCYTE Breast Cancer Risk Test
May 22, 2013 / Pharmacogenomics Reporter - Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News - Cancer Genetics Reports 45 Percent Increase in Q1 Revenues, Maps out Growth Strategy
May 16, 2013 / GenomeWeb Daily News